These findings suggest that etiology of tumor subtypes may vary by degree of pre-existing obesity of the patient and propose novel insights into molecular mechanisms linking obesity, ER expression, and proliferation to breast tumor development. Here, ESR1 is linked to obesity due to melanocortin 4 receptor deficiency.